Mainz Biomed (MYNZ) Institutional Ownership $2.93 -0.28 (-8.72%) Closing price 04:00 PM EasternExtended Trading$2.92 -0.01 (-0.34%) As of 06:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Mainz Biomed (NASDAQ:MYNZ)Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$79.19KNumber ofInstitutional Sellers(last 12 months)0 Get MYNZ Insider Trade Alerts Want to know when executives and insiders are buying or selling Mainz Biomed stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Remove Ads Mainz Biomed Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/11/2025Virtu Financial LLC18,330$79K0.0%N/A0.917% 5/17/2022Greenwich Investment Management Inc.14,724$215K0.1%N/A0.000% (Data available from 1/1/2016 forward)Remove Ads MYNZ Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of MYNZ shares? During the previous two years, the following institutional investors and hedge funds held shares of Mainz Biomed shares: Virtu Financial LLC ($79K).Learn more on MYNZ's institutional investors. Which institutional investors have been buying Mainz Biomed stock? The following institutional investors have purchased Mainz Biomed stock in the last 24 months: Virtu Financial LLC ($18.33K). How much institutional buying is happening at Mainz Biomed? Institutional investors have bought a total of 18,330 shares in the last 24 months. This purchase volume represents approximately $79.19K in transactions. Related Companies Cadrenal Therapeutics Major Shareholders CASI Pharmaceuticals Major Shareholders FibroGen Major Shareholders Tempest Therapeutics Major Shareholders OS Therapies Major Shareholders Estrella Immunopharma Major Shareholders MiNK Therapeutics Major Shareholders Reviva Pharmaceuticals Major Shareholders NRx Pharmaceuticals Major Shareholders Exicure Major Shareholders This page (NASDAQ:MYNZ) was last updated on 4/1/2025 by MarketBeat.com Staff From Our PartnersA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredRetirement Nightmare? It’s Already Happening.The market is on edge. Every day, another company slashes its dividend, leaving investors scrambling. Intel...Investors Alley | SponsoredNew “Trump” currency proposed in DCA former U.S. Presidential Advisor has come forward with a stern warning to investors: “Get out of tech, no...Paradigm Press | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredBrace Yourself for Jeff Bezos’ “Amazon Helios”Jeff Bezos quietly backing world-changing tech (not AI) The Amazon founder is quietly advancing a radical t...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mainz Biomed Please log in to your account or sign up in order to add this asset to your watchlist. Share Mainz Biomed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
